Trials / Conditions / Recurrent Squamous Cell Carcinoma of the Head and Neck
Recurrent Squamous Cell Carcinoma of the Head and Neck
5 registered clinical trials studyying Recurrent Squamous Cell Carcinoma of the Head and Neck — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | 5-Fluorouracil Response and Optimization STudy (The FROST Trial) NCT07419464 | Washington University School of Medicine | Phase 2 |
| Withdrawn | ASTX727 and Nivolumab in Squamous Cell Carcinoma of the Head and Neck NCT06357858 | Case Comprehensive Cancer Center | Phase 1 |
| Unknown | A Clinical Trial of TQB2618 Injection Combined With Penpulimab Injection and Chemotherapy Versus Penpulimab In NCT05783921 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Phase 1 / Phase 2 |
| Completed | A Phase 2 Open Label Study of BA3021 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the H NCT05271604 | BioAtla, Inc. | Phase 2 |
| Completed | Duvelisib Plus Docetaxel In Recurrent/Metastatic HNSCC NCT05057247 | Glenn J. Hanna | Phase 2 |